Imaging the Effects of Castration on Bone Turnover and Hormone-Independent Prostate Cancer Colonization of Bone

被引:5
|
作者
Cross, N. A. [1 ]
Fowles, A. [2 ]
Reeves, K. [2 ]
Jokonya, N. [2 ]
Linton, K. [2 ]
Holen, I. [2 ]
Hamdy, F. C. [2 ]
Eaton, C. L. [2 ]
机构
[1] Sheffield Hallam Univ, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England
[2] Univ Sheffield, Sch Med, Urol Sect, Sheffield, S Yorkshire, England
来源
PROSTATE | 2008年 / 68卷 / 15期
基金
英国医学研究理事会;
关键词
androgens; osteolytic; osteoblast; osteoclast;
D O I
10.1002/pros.20833
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
INTRODUCTION. Tumor populations may selectively colonize bone that is being actively remodeled. In prostate cancer patients, androgen deprivation directly inhibits tumor growth initially, whilst induced bone loss may facilitate tumor colonization of bone by androgen-insensitive cells. We have tested this hypothesis using a xenograft model of early growth of prostate cancer in bone. METHODS. PC3 cells transfected with Green fluorescent protein (GFP) were injected into castrated and non-castrated athymic mice via intrabial and intracardiac routes. In vivo tumor growth was monitored daily and animals sacrificed 6-9 days following initial GFP-based detection of tumors. Tumor bearing and contra-lateral non-tumor bearing tibias were analyzed extensively by micro-CT and histology/immunohistochemistry for the presence of tumor cells and the effects of tumor and/or castration on bone cells and bone structure evaluated. RESULTS. GFP-positive tumors in bone were visible from 12 days post-injection following intratibial injection, allowing tumors <1 mm diameter to be monitored in live animals. Castration did not affect tumor frequency, tumor volume, or time to initial appearance of tumors injected via intratibial or intracardiac routes. Castration decreased trabecular bone volume in all mice. Significant tumor-induced suppression of numbers of osteoblasts, coupled with increased numbers of activated osteoclasts, was evident in both intact animals and castrated animals. CONCLUSIONS. In vivo GFP imaging allows the detection of early tumor growth at intra-osseous sites. Castration induces bone loss, but PC3-GFP cells are also capable of inducing bone remodeling in intact animals at early time points, independently of pre-existing castration-induced alterations to bone. Prostate 68: 1707-1714, 2008. (C) 2008 Wiley-Liss, Inc.
引用
收藏
页码:1707 / 1714
页数:8
相关论文
共 50 条
  • [31] Osteosclerotic Prostate Cancer Metastasis to Murine Bone: Enhanced with Increased Bone Turnover
    Buttke, P. C.
    Paul, E. M.
    Sikes, R. A.
    Gomes, R. R., Jr.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S185 - S185
  • [32] Implications of Serum Bone Turnover Markers in Prostate Cancer Patients With Bone Metastasis
    Kamiya, Naoto
    Suzuki, Hiroyoshi
    Yano, Masashi
    Endo, Takumi
    Takano, Makoto
    Komaru, Atsuhi
    Kawamura, Koji
    Sekita, Nobuyuki
    Imamoto, Takashi
    Ichikawa, Tomohiko
    UROLOGY, 2010, 75 (06) : 1446 - 1451
  • [33] CLINICAL OUTCOMES OF SERUM BONE TURNOVER MARKERS IN PROSTATE CANCER WITH BONE METASTASIS
    Kamiya, Naoto
    Suzuki, Hiroyoshi
    Endo, Takumi
    Takano, Makoto
    Yano, Masashi
    Naoi, Makito
    Kawamura, Koji
    Kawamura, Koji
    Imamoto, Takashi
    Ichikawa, Tomohiko
    JOURNAL OF UROLOGY, 2012, 187 (04): : E899 - E899
  • [34] Markers of bone turnover for the management of patients with bone metastases from prostate cancer
    P Garnero
    N Buchs
    J Zekri
    R Rizzoli
    R E Coleman
    P D Delmas
    British Journal of Cancer, 2000, 82 : 858 - 864
  • [35] The Effects of Chemical Castration with Degarelix on Bone Turnover: Densitometric and Biomechanics Bone Properties of Male Rats
    Jayusman, Putri Ayu
    Mohamed, Isa Naina
    Shuid, Ahmad Nazrun
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2018, 16 (03)
  • [36] Markers of bone turnover for the management of patients with bone metastases from prostate cancer
    Garnero, P
    Buchs, N
    Zekri, J
    Rizzoli, R
    Coleman, RE
    Delmas, PD
    BRITISH JOURNAL OF CANCER, 2000, 82 (04) : 858 - 864
  • [37] Markers of bone turnover and disease status in prostate cancer
    Hannon, RA
    Wells, JM
    Hamdy, FC
    Hoyle, N
    Eastell, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (07) : 1372 - 1372
  • [38] EFFECTS OF PARATHYROID HORMONE ON PHOSPHATE TURNOVER IN BONE AND KIDNEY
    EGAWA, J
    NEUMAN, WF
    ENDOCRINOLOGY, 1963, 72 (03) : 370 - +
  • [39] Markers of bone turnover in prostate cancer - Discussion two
    Rubens
    Coleman
    Fraser
    Moro
    Lipton
    Bundred
    Demers
    Seibel
    Hamdy
    Eastell
    Hilkens
    Garnero
    CANCER TREATMENT REVIEWS, 2001, 27 (03) : 193 - 196
  • [40] RISEDRONATE PREVENTS EARLY BONE LOSS AND INCREASED BONE TURNOVER IN THE FIRST 6 MONTHS OF LUTEINIZING HORMONE RELEASING HORMONE AGONIST THERAPY FOR PROSTATE CANCER
    Taxel, Pamela
    Dowsett, Robert
    Richter, Lee
    Fall, Pamela
    Kleppinger, Alison
    Albertsen, Peter
    JOURNAL OF UROLOGY, 2010, 183 (04): : E336 - E337